Lam Research (NASDAQ:LRCX) Stock Price Down 4.2% – What’s Next?

Lam Research Corporation (NASDAQ:LRCX)’s share price dropped 4.2% during mid-day trading on Thursday . The company traded as low as $230.70 and last traded at $239.07. Approximately 10,622,218 shares traded hands during trading, a decline of 15% from the average daily volume of 12,474,908 shares. The stock had previously closed at $249.48.

Wall Street Analysts Forecast Growth

Several research firms recently commented on LRCX. Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 price objective (up from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Cantor Fitzgerald restated an “overweight” rating and set a $320.00 target price (up from $265.00) on shares of Lam Research in a report on Thursday, January 29th. KeyCorp reiterated a “sector weight” rating on shares of Lam Research in a research note on Thursday, January 29th. TD Cowen increased their price target on Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a report on Thursday, January 29th. Finally, Citic Securities upped their target price on shares of Lam Research from $165.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.19.

Lam Research Trading Down 4.2%

The company has a fifty day moving average of $214.18 and a 200-day moving average of $163.37. The firm has a market capitalization of $298.54 billion, a PE ratio of 48.99, a price-to-earnings-growth ratio of 2.62 and a beta of 1.78. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the business posted $0.91 earnings per share. The firm’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is 21.31%.

Insider Buying and Selling at Lam Research

In other news, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the sale, the director owned 253,705 shares in the company, valued at $57,235,848. The trade was a 12.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.31% of the stock is currently owned by insiders.

Institutional Trading of Lam Research

Hedge funds and other institutional investors have recently modified their holdings of the company. PMV Capital Advisers LLC bought a new position in Lam Research during the fourth quarter worth about $25,000. Stance Capital LLC bought a new stake in Lam Research during the third quarter worth about $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the 2nd quarter valued at $27,000. Triumph Capital Management bought a new stake in shares of Lam Research during the 3rd quarter valued at approximately $27,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in shares of Lam Research during the 4th quarter valued at $27,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.